IA
CRMD icon

IFP Advisors’s CorMedix CRMD Stock Holding History

IFP Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.7K Buy
+2,751
New +$20.3K ﹤0.01% 2815
2025
Q3 		– Sell
-9
Closed -$677 – 4852
2025
Q2 		$677 Buy
+9
New +$99 ﹤0.01% 4343
2025
Q1 		– Sell
-5
Closed -$40 – 4384
2024
Q4 		$40 Buy
+5
New +$50 ﹤0.01% 4316

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

IFP Advisors's CRMD Position: Q1 2026 in Review

IFP Advisors opened a new position in CorMedix (CRMD) in Q1 2026: 2,751 shares worth $18.7K. The stake represents ﹤0.01% of the portfolio and ranks #2815 among its holdings. This is a return to the name: IFP Advisors previously reported a position in CRMD as recently as Q2 2025.

IFP Advisors first reported a position in CRMD in Q4 2024 and has held it in 3 quarters since. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • IFP Advisors held 2,751 shares of CorMedix worth $18.7K as of Q1 2026.
  • CorMedix was a new IFP Advisors position in Q1 2026.
  • CorMedix made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #2815 holding.
  • IFP Advisors first reported a position in CorMedix in Q4 2024 and has held it in 3 quarters since.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.